Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Period:
Draw Mode:
| Volume | 0.00 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Sigyn Therapeutics Inc (QB) | SIGY | OTCMarkets | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.00 | 0.0% | 0.195 | 11:12:53 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 0.195 |
| Trades | Volume | Avg Volume | 52 Week Range |
|---|---|---|---|
| 0 | 0.00 | - | 0.052 - 0.48 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| - | 0 | $ 0.195 | USD |
Sigyn Therapeutics Inc (QB) Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 8.62M | 44.22M | 8.63M | - | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Sigyn Therapeutics (QB) News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical SIGY Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.176 | 0.195 | 0.14 | 0.1612934 | 10,567 | 0.019 | 10.8% |
| 1 Month | 0.141 | 0.195 | 0.14 | 0.155653 | 9,317 | 0.054 | 38.3% |
| 3 Months | 0.20 | 0.28 | 0.14 | 0.1889578 | 7,576 | -0.005 | -2.5% |
| 6 Months | 0.085 | 0.32 | 0.052 | 0.1626723 | 11,158 | 0.11 | 129.41% |
| 1 Year | 0.2499 | 0.48 | 0.052 | 0.21961 | 17,346 | -0.0549 | -21.97% |
| 3 Years | 1.55 | 3.50 | 0.052 | 0.5209275 | 6,747 | -1.36 | -87.42% |
| 5 Years | 1.8501 | 3.50 | 0.052 | 0.5513158 | 6,309 | -1.66 | -89.46% |
Sigyn Therapeutics (QB) Description
| Sigyn Therapeutics is a development-stage company focused on creating therapeutic solutions to address unmet needs in global health. Sigyn Therapy, the Companys lead product candidate, is a broad-spectrum blood purification technology designed to treat pathogen-associated inflammatory disorders that are not addressed with approved drug therapies. Candidate treatment indications for Sigyn Therapy include chronic inflammation and endotoxemia in end-stage renal disease patients, sepsis (leading cause of hospital deaths), community acquired pneumonia (a leading cause of death among infectious diseases), and emerging pandemic threats. The Company's development pipeline includes a cancer treatment system comprised of ChemoPrep to enhance the delivery of FDA approved chemotherapeutic agents and ChemoPure to reduce chemotherapy toxicity. |
